Dr. Kevin Schaab has over 25 years of experience in helping develop innovative pharmaceutical therapies, with significant experience in roles spanning pharmaceutical sciences (CMC), non-clinical development, first-in-human to proof-of concept clinical studies, and business development.  

At Quotient Sciences, Kevin is a member of the drug development consultancy team, and is responsible for working with our internal teams to help design and deliver early phase programs along with customer teams.

Kevin holds a PhD in Chemistry from the Florida State University, a Master’s degree in Business Administration from San Diego State University, and a Bachelor of Science degree in Chemistry from the University of Cincinnati.